When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Recent breakthroughs in understanding the prostaglandin D2 (PGD2) receptor 1 (DP1) are paving the way for innovative ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Dopamine, a small molecule derived from the amino acid tyrosine, plays a significant role in regulating multiple essential ...

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests.

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...

The compound provides non-opioid pain relief by targeting neurotensin receptor 1 (NTSR1) on sensory neurons and within the ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...

Mouse models treated with the sleep aid lemborexant had less brain damage compared to controls and mice that received a ...